Request Demo
Last update 24 Aug 2026
Ranibizumab Biosimilar (Apotex, Inc.)
Last update 24 Aug 2026
Overview
Basic Info
Drug Type Fab fragment, Biosimilar |
Synonyms Ranibizumab Biosimilar (Apotex, Inc.), 雷珠单抗生物类似药（Apotex, Inc.） |
Target |
Action inhibitors |
Mechanism VEGF-A inhibitors(Vascular endothelial growth factor A inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Canada (10 Jun 2026), |
Regulation- |
Login to view timeline
Structure/Sequence
Sequence Code 103170L
The sequence is quoted from: *****
Sequence Code 143622H
The sequence is quoted from: *****
External Link
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
R&D Status
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Diabetic macular oedema | Canada | 10 Jun 2026 | |
| Myopic choroidal neovascularization | Canada | 10 Jun 2026 | |
| Retinal vein occlusion-related macular edema | Canada | 10 Jun 2026 | |
| Retinopathy of Prematurity | Canada | 10 Jun 2026 | |
| Wet age-related macular degeneration | Canada | 10 Jun 2026 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free